Alnylam Pharma Stock Price (NASDAQ:ALNY)

Add to My Stocks
$51.35 $1.05 (2.09%) ALNY stock closing price Apr 25, 2017 (Closing)
YOUR DAILY UPDATE ON
ALNY
Alnylam Pharma
25 APR 2017
amigobulls logo
ALNY hand_up
ALNY vs S&P 500
Closing Price: Apr 25, 2017
ALNY
$51.35 ( 2.09%)
S&P 500
2388.6 ( 0.61%)
ALNY
52 Week Price Range
1 Year Return: -30.09%
Q4 Growth*
Excellent
Profitable ?
No
net image
2016 Q4 Net Loss
-869.6%
home image
Rating
ALNY POOR
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Alnylam Pharma Snapshot Video

13 5 2

ALNY Stock Details

Prev Close* : $50.30
Market Cap:
$4.33B
Day Low: $50.39
52 Week Low: $31.38
Open: $50.64
Volume: 475453
Day High: $51.91
52 Week High: $80.11
Dividend:
N/A

Latest Stock Market News

Latest Articles

Alnylam Pharma News - From Partners

ALNY Stockcharts

View ALNY PE ratio, PS ratio stocks charts and compare with peers.
ALNY Chart
Note: Compare Alnylam Pharma stock price history with the index and industry peers.

Alnylam Pharma Valuation

PS ratio (
price to sales ratio
)
93.47
PB ratio (
price to book ratio
)
4.02

Alnylam Pharma Financial Ratios

Asset Turnover
0.05
Receivables Turnover
3.62
Debt to Equity
0.16

ALNY Industry Peers

Company Price Change (%)
Dyax (DYAX)38.410 (0%)
Kite Pharma (KITE)80.571.68 (2.04%)
Arrowhead Pharma (ARWR)1.520.04 (2.7%)
Regulus Therapeutics (RGLS)1.450.05 (3.57%)
Benitec Biopharma (BNTC)2.650.01 (0.38%)
Sanofi (SNY)46.40.5 (1.09%)
Takeda Pharma (TKPYY)24.250.15 (0.61%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Epizyme (EPZM)17.452.55 (17.11%)
Sangamo BioSciences (SGMO)4.750.45 (10.47%)
Fortress Biotech (FBIO)3.570.29 (8.84%)
Idera Pharma (IDRA)2.4350.19 (8.44%)
Achillion Pharma (ACHN)3.480.27 (8.41%)
Revance (RVNC)22.451.55 (7.42%)
Immunomedics (IMMU)5.440.36 (7.08%)
Top gainers from Medical-Biomed-Genetics industry
* As of Apr 26, 2017
CompanyPriceChange (%)
AKARI THERAPTC (AKTX)15.252.24 (12.81%)
The Medicines Company (MDCO)49.112.34 (4.55%)
Kindred Biosciences (KIN)6.850.3 (4.2%)
ALBIREO PHARMA (ALBO)21.610.37 (1.68%)
Repligen (RGEN)34.630.48 (1.37%)
Cara Therapeutics (CARA)16.390.22 (1.32%)
NOVELION THERAP (NVLN)10.090.12 (1.18%)
Top losers from Medical-Biomed-Genetics industry
* As of Apr 26, 2017

Alnylam Pharmaceuticals, Inc. Stock News - Partner Headlines

Alnylam Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues47.15M41.09M50.56M47.16M66.72M
Net Income-410.1M-290.07M-360.39M-89.22M-106.01M
Total Operating Expense471.74M337.1M455.53M140.1M196.17M
view Alnylam Pharmaceuticals, Inc. income statement
balance sheet20162015201420132012
Total Assets1.26B1.39B1.08B420.53M287.52M
Total Liabilities342.58M121.79M143.32M150.18M153.46M
Shareholders Equity920.22M1.26B936.26M270.34M134.05M
view Alnylam Pharmaceuticals, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities17.21M35.11M-29.4M-8.11M-8.96M
Net Cash From (Used By) Operating Activities-307.7M-189.14M-165.64M-68.65M-115.6M
Increase (Decrease) In Prop Plant And Equipment-64.55M-12.95M-8.96M-4M-8.34M
view Alnylam Pharmaceuticals, Inc. cashflow statement

Alnylam Pharma Stock Message Board

Alnylam Pharma stock price ended the last trading day at 51.35. Stock price or share price can be used to find the total market value of a company. Alnylam Pharma market cap stands at 4.33B as of 25 Apr, 2017. A value investor must look at the fundamentals of a stock, and perform Alnylam Pharma valuation, even though in the short-term sentiment and current breaking news might affect Alnylam Pharma stock price.

For recognizing and analyzing the real performance of Alnylam Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 475453 shares were traded with a closing stock price of 51.35 as of 25 Apr, 2017, as can be seen from Alnylam Pharma stock quote. One can view Alnylam Pharma stock chart to follow the stock price trend. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. One can observe stock price trends and check for volatility by checking Alnylam Pharma stock price history.